Big Caring Group Plans RM3 Billion IPO: What Investors Should Know

Bursa Malaysia is set to witness another major IPO from the healthcare sector. According to Bloomberg reports cited by The Edge Malaysia, Big Caring Group Bhd, Malaysia's largest pharmacy chain, is planning an Initial Public Offering (IPO) that could raise up to RM3 billion - potentially one of Bursa Malaysia's biggest IPOs in over a decade.

If you just witnessed the success of Sunway Healthcare's IPO in March 2026 that surged 28% on debut day and was added straight into FBM KLCI, you might be wondering - will Big Caring continue that trend? And more importantly: what should you know before applying for this IPO?

In this article, I unpack everything important about the Big Caring IPO - from the company background, offering structure, financial performance, the role of private equity backer Creador, to what this IPO means for Malaysian retail investors.

Quick Answer

Big Caring Group Bhd, operator of Malaysia's largest pharmacy network with 626 outlets (under brands BIG Pharmacy, CARiNG Pharmacy, Georgetown Pharmacy, Wellings and Ting Pharmacy), is seeking up to RM3 billion (~USD750 million) through an IPO on Bursa Malaysia's Main Market, targeted by October 2026. The company is offering up to 25.5% of enlarged share capital, with proceeds going to reduce debt from the Caring Pharmacy acquisition and fund a new automated distribution centre in Klang. Backed by Creador (~33.7% pre-IPO stake, reduced to 19.4% post-listing), Big Caring posted FY2025 revenue of RM3.41 billion and net profit of RM143 million.

What Is Big Caring Group?

Big Caring Group is the result of merging Malaysia's two largest retail pharmacy brands - BIG Pharmacy and Caring Pharmacy - after BIG Pharmacy acquired Caring Pharmacy from 7-Eleven Malaysia Holdings Bhd in late 2023 for approximately RM900 million.

After that acquisition, the group became Malaysia's largest retail pharmacy operator by outlet count. They operate under several brands:

• BIG Pharmacy - main brand
• CARiNG Pharmacy - acquired chain
• Georgetown Pharmacy - Penang presence
• Wellings
• Ting Pharmacy

According to The Edge's report on their prospectus filing, the group currently operates 626 outlets across Malaysia - making them the dominant player in the local retail pharmacy sector.

Business Scale: More Than Just Pharmacies

It's important to understand that Big Caring isn't merely a "medicine store" chain. Modern pharmacy networks in Malaysia generate revenue from multiple categories:

1. Prescription drugs (Rx) - medication requiring doctor's prescription
2. OTC medication (over-the-counter) - panadol, paracetamol, allergy meds
3. Health products and vitamins - supplements, vitamins, herbs
4. Beauty and dermatology products - skincare, dermatology cosmetics
5. Baby and children products - formula milk, baby food
6. Consumer products - from energy drinks to personal care items

Industry trends show the highest margins come from vitamins, supplements and beauty categories - not from prescription drugs (which usually have low margins). This is the same pattern as global pharmacies - Watsons, Boots, Guardian Asia all rely on high-margin products.

Creador Backing: Private Equity Capital As Catalyst

One of the most important factors behind Big Caring's success is the support from private equity firm Creador Sdn Bhd, a PE firm based in South and Southeast Asia.

Creador first invested in the pharmacy chain in 2015, and currently holds about 34% stake in the company through special purpose vehicle Iris Pallida Sdn Bhd (IPSB). After listing, IPSB's stake will be reduced from 33.7% to 19.4%, and if the over-allotment option for price stabilisation is fully exercised, it could drop further to 16.3%.

What does this mean for retail investors?

1. PE backing - usually viewed positively as PE firms bring operational discipline, tight financial management, and clear growth strategy.
2. But PE exit at IPO means they "cash out" - there's a conflict of interest between getting a high IPO price (for PE) and a reasonable price for retail investors.
3. Post-IPO monitoring - Creador remains a major shareholder (19.4%), meaning they still have incentive for the company to perform, but less than before.

Financial Performance: Numbers To Watch

Here are the key numbers from Big Caring's prospectus (financial year ending 30 June 2025):

• Revenue: RM3.41 billion
• Net profit: RM143 million
• Net profit margin: ~4.2%
• Same-store sales growth (SSSG): 9.6% in FY2025 (up from 7.3% in FY2024)

The ~4.2% margin is typical for pharmacy retailers - it's not a high-margin business like software, but has high volume and repeat customers. They serve many customers daily with small but consistent basket sizes.

What's more interesting is the 9.6% same-store sales growth - meaning existing stores (not newly opened ones) grew almost 10%. This indicates: - Consumer demand for pharmacy products is sustained - Pricing and product strategy is working - Not just growth from adding new outlets

For comparison, conventional retailers in Malaysia typically post SSSG of ~3-5% in normal economic conditions. 9.6% is an exceptional result.

IPO Structure: What Will Happen On Launch Day?

According to reported information, the Big Caring IPO structure will be:

• Size: Up to RM3 billion (~USD750 million)
• Share offering percentage: Up to 25.5% of enlarged share capital
• Market: Bursa Malaysia Main Market
• Target timeline: Around October 2026
• Implicit valuation: ~RM11.7 billion (if RM3B = 25.5%)

For context: at ~RM11.7 billion market cap, Big Caring would become one of the largest pharmacy/health retail companies on Bursa Malaysia.

What Will The IPO Proceeds Be Used For?

According to The Edge's report, Big Caring filed their prospectus stating two main purposes:

1. Reduce Debt From Acquisition

The Caring Pharmacy acquisition in 2023 (RM900 million) was largely funded with debt. IPO proceeds will be used to pay down this debt, reducing interest costs and strengthening the company's balance sheet.

2. Fund New Automated Distribution Centre

Big Caring has begun building a new automated distribution centre in Klang in preparation for the IPO. According to The Edge's report, this centre will automate logistics and inventory processes for all 626 outlets, improving operational efficiency.

This strategy is sensible - reducing debt + improving operational efficiency = higher margins going forward.

Comparison With Sunway Healthcare IPO

For Malaysian investors, the Big Caring IPO will automatically be compared with Sunway Healthcare Holdings Bhd which just listed in March 2026.

What happened in the Sunway Healthcare IPO:

• Amount raised: ~RM3 billion (Malaysia's biggest IPO in 9 years)
• IPO price: RM1.45 per share
• Debut day: opened +17% at RM1.70, peak RM2.07, closed +28% at RM1.85
• Retail demand: oversubscribed 6 times
• Post-listing market cap: RM21.3 billion
• Added to FBM KLCI effective 25 March 2026

If Big Caring successfully raises RM3 billion, it would match or exceed Sunway Healthcare as Malaysia's biggest IPO this year.

But there are important differences: - Sunway Healthcare is a hospital operator (B2B/B2C, capital intensive) - Big Caring is a retail pharmacy chain (B2C, capital-light, high volume)

Their margins, growth dynamics and risk profile differ even though both are in the "healthcare sector".

Sector Signal: Bursa Malaysia Healthcare Investment Is Rising

The Big Caring IPO comes at an interesting time. Bursa Malaysia's healthcare sector is experiencing strong investor pull for several reasons:

1. Ageing demographics - Malaysia is facing an ageing society with expected rising health demand
2. Rising disposable income - Malaysians are willing to spend more on health and beauty
3. Self-medication and preventive health trends - vitamins, supplements going mainstream
4. Defensive sector - healthcare is relatively recession-resistant (people still need medicine regardless of economy)

This makes the healthcare sector, as explained in Bursa Malaysia corporate recap roundup, one of the main investment themes for 2026.

What Should Retail Investors Consider Before Applying?

This is not investment advice - just a framework for readers' consideration:

Positive Points

• Market leader with 626 outlets (hard for new competitors to catch up)
• SSSG of 9.6% shows real momentum, not artificial growth
• Clear use of proceeds (reduce debt + automation)
• Backed by experienced PE (Creador)
• Healthcare sector is a strong investment theme

Things To Be Cautious About

• Thin ~4.2% margin - any operational disruption can hit profit
• PE exit - Creador reducing stake has valuation implications
• IPO valuation - at ~RM11.7B market cap, PE ratio is around 80x. Is this too expensive?
• Saturated market - Watsons, Guardian, AEON Pharmacy are strong competitors
• Regulatory risk - pharmacy sector subject to MOH and Poisons Act 1952 regulations

Key Questions Before Applying

1. Do I believe in the long-term growth thesis?
2. Is the valuation (PE ratio) worth it at the IPO price?
3. Am I willing to hold long-term or just "flip" on debut day?

These considerations align with what Peter Lynch teaches in One Up on Wall Street - understand the business you invest in, don't follow the hype.

FAQ: Common Questions About Big Caring IPO

Q: When is the Big Caring IPO? A: Targeted by October 2026, although timing details may change. Exact dates will be announced when the IPO prospectus is approved by Securities Commission Malaysia and Bursa Malaysia.

Q: How much is Big Caring looking to raise? A: Up to RM3 billion (~USD750 million) - potentially one of Bursa Malaysia's biggest IPOs in over a decade.

Q: How many outlets does Big Caring have now? A: 626 outlets across Malaysia, under brands BIG Pharmacy, CARiNG Pharmacy, Georgetown Pharmacy, Wellings and Ting Pharmacy.

Q: Who is Creador and what's their role? A: Creador is a private equity (PE) firm that has invested in BIG Pharmacy since 2015. They hold ~33.7% pre-IPO and will reduce to 19.4% (or 16.3% if over-allotment is fully exercised) post-listing.

Q: How much revenue and profit did Big Caring make last year? A: For FY2025 (ending 30 June 2025): Revenue RM3.41 billion, net profit RM143 million, with same-store sales growth of 9.6%.

Q: What's the difference between Big Caring and Sunway Healthcare IPOs? A: Sunway Healthcare is a hospital operator (capital intensive), Big Caring is a retail pharmacy chain (capital-light, high volume). Both are in healthcare but business profiles differ.

Q: Should I apply for the Big Caring IPO? A: Depends on your investment thesis, risk tolerance, and your view on the IPO price. Usually it's wise to wait for the full prospectus and research house analysis before deciding.

Q: How do I apply for an IPO on Bursa Malaysia? A: You need a CDS account. Applications can be made through brokers during the IPO subscription period, usually 2 weeks before the listing date.

Q: What happens if the IPO is oversubscribed? A: Applications will be balloted or pro-rated. For Sunway Healthcare, retail was oversubscribed 6 times - so each applicant got slightly less than what they applied for.

Conclusion

The Big Caring Group IPO is one of Bursa Malaysia's main market events for 2026 - potentially matching or exceeding Sunway Healthcare as the biggest IPO of the year. With 626 outlets, same-store sales growth of 9.6%, Creador PE backing, and clear use of proceeds strategy, it's a strong IPO story. But retail investors need to carefully review the valuation (PE ratio), sector risks, and long-term growth thesis before applying.

Before you can apply for IPOs like Big Caring or invest in healthcare stocks on Bursa Malaysia, you need market access through a licensed platform.

Open a CDS account to apply for the Big Caring IPO and invest in Bursa Malaysia as well as foreign stocks like US and Hong Kong - allowing you to participate in the growing healthcare investment opportunities.

For the fundamentals of fundamental analysis and IPO company valuation, download our Stock Investing Basics Ebook for free.

Further Reading

• Bursa Malaysia Recap: 1QFY26 Reports & Corporate Actions May 2026
• Bursa Malaysia Targets Quality Over Quantity: RM28 Billion IPO Focus For 2026
• How To Read Income Statement: Understanding Revenue, Net Profit & Company Cash Reality
• PE Ratio: How To Know If Stocks Are Cheap Or Expensive By Sector In Malaysia
• One Up on Wall Street Summary: What Peter Lynch's Lessons Mean For Malaysian Investors